Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Surgical Equipment

Ion Beam Applications S.A.: PROTEUS 235 Proton Therapy System Recalled for Radiation Control Failure

Agency Publication Date: June 3, 2024
Share:
Sign in to monitor this recall

Summary

Ion Beam Applications S.A. is recalling 2 units of the IBA Proton Therapy System - PROTEUS 235 (PTS-11 and PTS-12 versions with C230 accelerator) because the system may fail to stop irradiation even when critical control parameters are outside of safe tolerances. This defect means the accelerator control unit might not interrupt the proton beam as designed during patient treatment. These units were distributed in the state of Virginia and in India.

Risk

The failure of the control unit to interrupt irradiation when parameters are out of tolerance could lead to patients receiving unintended or excessive radiation doses during cancer treatment. While no specific injuries were reported in this notification, radiation delivery errors can cause serious tissue damage or ineffective treatment of tumors.

What You Should Do

  1. Identify if your facility is using the IBA Proton Therapy System - PROTEUS 235 with a C230 accelerator, specifically serial numbers SAT136 or SAT140.
  2. Check the system software version to see if it is PTS-11 (starting from version 11.1) or PTS-12.
  3. Verify the Unique Device Identifier (UDI) on your equipment: (01)05404013814015(11)190507(21)SAT140 or (01)05404013801138(11)201105(21)SAT136.
  4. Contact your healthcare provider or Ion Beam Applications S.A. immediately for technical instructions regarding the Accelerator Control Unit parameters and potential software updates or hardware adjustments.
  5. Medical professionals should monitor system logs closely for any instances where parameters exceeded tolerances without an automatic beam interruption.
  6. For further information or to report concerns, contact the FDA at 1-888-463-6332 or visit www.fda.gov/medical-devices/medical-device-recalls.

Your Remedy Options

๐Ÿ“‹Other Action

Manufacturer initiated technical correction

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: IBA Proton Therapy System - PROTEUS 235
Model / REF:
PTS-11 (versions from 11.1)
PTS-12
C230 Accelerator
Lot Numbers:
Serial Number SAT136
Serial Number SAT140

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94576
Status: Active
Manufacturer: Ion Beam Applications S.A.
Sold By: Ion Beam Applications S.A.
Manufactured In: Belgium
Units Affected: 2 units
Distributed To: Virginia

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.